Extracellular Fluid Volume and Mortality after Kidney Transplantation.
Journal
Kidney360
ISSN: 2641-7650
Titre abrégé: Kidney360
Pays: United States
ID NLM: 101766381
Informations de publication
Date de publication:
09 Oct 2024
09 Oct 2024
Historique:
received:
07
01
2024
accepted:
17
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
9
10
2024
Statut:
aheadofprint
Résumé
High extracellular fluid volume (ECV) is associated with an increased risk of death in non-transplanted patients with chronic kidney disease (CKD). By contrast, both the determinants and the prognosis value of ECV in kidney transplant recipients (KTR) remain unclear. We studied a bicentric prospective cohort of 2057 KTR, who underwent glomerular filtration rate measurement (mGFR) three months after transplantation. We calculated ECV from iohexol plasma disappearance curve and analyzed its association with patient's characteristics and outcomes. Mean ECV and mGFR were 14.6±2.6L/1.73m2 and 52±16mL/min/1.73m2, respectively. Multiple linear regression identified male gender, older donor and recipient ages, deceased donor, non-preemptive transplantation, diabetes, cardiac arrhythmia, heart failure, proteinuria and higher mGFR as independent factors associated with increased ECV. In multivariable cause specific cox analyzes, higher tertiles of ECV were associated with increased mortality [tertile 1 as reference; hazard ratio (95% confidence interval) for tertile 2: 1.65 (1.11-2.47); tertile 3: 1.80 (1.18-2.74)] but not graft loss. Increased ECV, 3 months after transplantation, was a predictor of reduced mGFR at 12 months after adjusting for three months mGFR and other confounding factors (β coefficient: -0.06; 95%CI [-0.09 to -0.02]). an elevated ECV 3 months after KT is independently associated with increased mortality and decreased mGFR at 12 months, but not with graft loss.
Sections du résumé
BACKGROUND
BACKGROUND
High extracellular fluid volume (ECV) is associated with an increased risk of death in non-transplanted patients with chronic kidney disease (CKD). By contrast, both the determinants and the prognosis value of ECV in kidney transplant recipients (KTR) remain unclear.
METHODS
METHODS
We studied a bicentric prospective cohort of 2057 KTR, who underwent glomerular filtration rate measurement (mGFR) three months after transplantation. We calculated ECV from iohexol plasma disappearance curve and analyzed its association with patient's characteristics and outcomes.
RESULTS
RESULTS
Mean ECV and mGFR were 14.6±2.6L/1.73m2 and 52±16mL/min/1.73m2, respectively. Multiple linear regression identified male gender, older donor and recipient ages, deceased donor, non-preemptive transplantation, diabetes, cardiac arrhythmia, heart failure, proteinuria and higher mGFR as independent factors associated with increased ECV. In multivariable cause specific cox analyzes, higher tertiles of ECV were associated with increased mortality [tertile 1 as reference; hazard ratio (95% confidence interval) for tertile 2: 1.65 (1.11-2.47); tertile 3: 1.80 (1.18-2.74)] but not graft loss. Increased ECV, 3 months after transplantation, was a predictor of reduced mGFR at 12 months after adjusting for three months mGFR and other confounding factors (β coefficient: -0.06; 95%CI [-0.09 to -0.02]).
CONCLUSION
CONCLUSIONS
an elevated ECV 3 months after KT is independently associated with increased mortality and decreased mGFR at 12 months, but not with graft loss.
Identifiants
pubmed: 39382974
doi: 10.34067/KID.0000000587
pii: 02200512-990000000-00489
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.